ID
52
Description
Repinotan in Patients With Acute Ischemic Stroke Inclusion Criteria: - Acute ischemic stroke of hemispheric localization (exclude brainstem and cerebellum), of suspected thromboembolic origin. - Males or females aged 18 years or over - National Institute of Health Stroke Scale (NIH-SS) total score 8 to 23 with a motor deficit >/= 2 (for either one arm or leg) and level of consciousness < 2 and at least one of the following: Visual field deficit, neglect, or aphasia. If a patient receives t-PA, NIH-SS must be performed prior to receiving the study drug but after infusion of t-PA is initiated. - Signed informed consent from patient or legally authorized representative Exclusion Criteria: - CT scan evidence of: -- Clearly defined areas of hypodensity indicating infarction of >1/3 of the MCA territory or evidence of significant mass effect with shift of midline or major areas of sulcal effacement associated with loss of cortical definition (grey-white distinction). Minor early CT changes are common in MCA strokes and patients with early or subtle changes are eligible. -- A primary intra-cerebral haemorrhage or any finding not consistent with an acute ischemic stroke as the cause of presenting symptoms. - Clinical evidence of acute stroke due to lacunar infarct (pure motor hemiplegia; pure sensory deficit, ataxia/clumsy hand syndromes) - Neurological (other than the presenting stroke) or psychiatric conditions that may affect the patient's functional status and/or that may interfere with the patient's assessment - Clinically relevant pre-existing neurological deficit (Historical Rankin score >/= 2 regardless of cause) - Generalized seizures having developed since the onset of stroke symptoms - Systolic blood pressure >210 or <110 mmHg (confirmed by up to three readings prior to randomization) - Diastolic blood pressure >110 or <60 mmHg (confirmed by up to three readings prior to randomization) - Myocardial infarction within 3 months, unstable angina within 3-5 days prior to starting infusion, unstable supra-ventricular and/or ventricular arrhythmia, severe conduction defect (AV block grades 2 and 3), complete left or right Bundle Branch Block, bradycardia (heart rate [HR] less than 50 bpm), uncompensated heart failure - History of myocarditis, cardiomyopathy or aortic stenosis - Patients known to have prolonged QTc intervals (inherited and sporadic syndromes of QTc prolongation or QTc interval >450 msec males and 470 msec females on baseline ECG) or using Class IA or Class III antiarrhythmic drugs (e.g., quinidine, procainamide, amiodarone, sotalol) - Any patients that require initiation of new digoxin therapy are excluded. Patients already on digoxin therapy (for at least 1 month stable dose) at time of enrollment will be allowed in the study. - Electrolyte imbalance at baseline. Should the results not be available before starting the study drug infusion, the patients will be allowed in the study providing that the corrective therapy of any abnormal electrolyte results is implemented immediately upon availability of the laboratory report. - Any conditions predisposing to electrolyte imbalances (e.g., chronic vomiting, anorexia nervosa, bulimia nervosa) will also be excluded at baseline. - Participation in a research protocol for investigation of a pharmaceutical agent or innovative invasive procedure (including intra-arterial t-PA) within the past 30 days - Previously in the BRAIN-Study or treated with repinotan - Life expectancy of less than 6 months due to comorbid conditions - Any other known clinically significant medical disorder (e.g., cardiovascular, gastrointestinal, hepatic, renal, endocrine, major uncompensated metabolic disturbances, respiratory, immunological, hematological or bleeding disorder, cancer, AIDS)
Mots-clés
Versions (3)
- 11/11/2011 11/11/2011 -
- 22/03/2014 22/03/2014 - Martin Dugas
- 17/09/2021 17/09/2021 -
Téléchargé le
11 novembre 2011
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY-NC 3.0 Legacy
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Criteria NCT00044915
Eligibility
- StudyEvent: Eligibility
Description
Exclusion criteria
Description
CT hypodensity
Type de données
boolean
Description
CT intra-cerebral haemorrhage
Type de données
boolean
Description
Lacunar infarct
Type de données
boolean
Description
Neurologic or psychiatric conditions
Type de données
boolean
Description
Pre-existing neurological deficit
Type de données
boolean
Description
Generalized seizures
Type de données
boolean
Description
Systolic blood pressure
Type de données
boolean
Description
Diastolic blood pressure
Type de données
boolean
Description
Myocardial infarction and arrhythmia
Type de données
boolean
Description
Myocarditis, cardiomyopathy, aortic stenosis
Type de données
boolean
Description
Qtc
Type de données
boolean
Description
Digoxin
Type de données
boolean
Description
Electrolyte imbalance
Type de données
boolean
Description
Electrolyte imbalance predisposition
Type de données
boolean
Description
Other protocols
Type de données
boolean
Description
Previously in BRAIN-Study
Type de données
boolean
Description
Life expectancy less than 6 months
Type de données
boolean
Description
Significant medical disorder
Type de données
boolean
Description
Medizinische Konzepte
Description
Diagnosis
Type de données
string
Alias
- UMLS CUI
- C0011900
- SNOMED CT 2010_0731
- 439401001
Description
Stroke
Type de données
string
Alias
- UMLS CUI
- C0038454
- SNOMED CT 2010_0731
- 230690007
- MedDRA 13.1
- 10042244
- ICD-10-CM Version 2010
- I63.9
- CTCAE Version 4.03
- E12826
Description
Age
Type de données
string
Alias
- UMLS CUI
- C0001779
- SNOMED CT 2010_0731
- 102518004
Description
NIH-SS
Type de données
string
Alias
- UMLS CUI
- C1697238
- MedDRA 13.1
- 10065527
Description
Pharmaceutical Preparations
Type de données
string
Alias
- UMLS CUI
- C0013227
Description
Diagnostic procedure
Type de données
string
Alias
- UMLS CUI
- C0430022
- SNOMED CT 2010_0731
- 103693007
- MedDRA 13.1
- 10061816
Description
CT scan
Type de données
string
Alias
- UMLS CUI
- C0040405
- MedDRA 13.1
- 10011603
Description
Ischemic stroke
Type de données
string
Alias
- UMLS CUI
- C0948008
- SNOMED CT 2010_0731
- 422504002
- MedDRA 13.1
- 10055221
Description
Hemorrhagic cerebral infarction
Type de données
string
Alias
- UMLS CUI
- C0472369
- SNOMED CT 2010_0731
- 230706003
- MedDRA 13.1
- 10019005
Description
Lacunar infarction
Type de données
string
Alias
- UMLS CUI
- C0333559
- SNOMED CT 2010_0731
- 81037000
- MedDRA 13.1
- 10051078
Description
Compliance
Type de données
string
Alias
- UMLS CUI
- C1321605
- SNOMED CT 2010_0731
- 405078008
Description
Rankin score
Type de données
string
Alias
- UMLS CUI
- CL423500
Description
Convulsions generalised
Type de données
string
Alias
- UMLS CUI
- C0234533
- SNOMED CT 2010_0731
- 246545002
- MedDRA 13.1
- 10010916
Description
Arterial blood pressure
Type de données
string
Alias
- UMLS CUI
- C1272641
- SNOMED CT 2010_0731
- 386534000
Description
CHD
Type de données
string
Alias
- UMLS CUI
- C0010068
- SNOMED CT 2010_0731
- 53741008
- MedDRA 13.1
- 10068617
- ICD-10 Version 2009
- I25.1
Description
Cardiac Arrhythmia
Type de données
string
Alias
- UMLS CUI
- C0003811
- SNOMED CT 2010_0731
- 44808001
- MedDRA 13.1
- 10003119
- ICD-10-CM Version 2010
- I49.9
- ICD-9-CM Version 2011
- 427.9
Description
Heart failure
Type de données
string
Alias
- UMLS CUI
- C0018801
- SNOMED CT 2010_0731
- 155374007
- MedDRA 13.1
- 10019279
- ICD-10-CM Version 2010
- I50
- ICD-9-CM Version 2011
- 428
- CTCAE Version 4.03
- E10124
Description
Cardiac disease
Type de données
string
Alias
- UMLS CUI
- C0018799
- SNOMED CT 2010_0731
- 56265001
- MedDRA 13.1
- 10061024
Description
Prolonged QTc interval
Type de données
string
Alias
- UMLS CUI
- C1560305
Description
Antiarrhythmic drug
Type de données
string
Alias
- UMLS CUI
- C0003195
- SNOMED CT 2010_0731
- 67507000
Description
Potassium
Type de données
string
Alias
- UMLS CUI
- C0202194
- SNOMED CT 2010_0731
- 88480006
- LOINC
- 2823-3
- MedDRA 13.1
- 10036439
Description
Sodium
Type de données
string
Alias
- UMLS CUI
- C0037473
- SNOMED CT 2010_0731
- 39972003
- LOINC
- 2951-2
- MedDRA 13.1
- 10041263
Description
Enrollment
Type de données
string
Alias
- UMLS CUI
- C1516879
Description
Life expectancy
Type de données
string
Alias
- UMLS CUI
- C0023671
- LOINC Version 232
- LP75025-4
Similar models
Eligibility
- StudyEvent: Eligibility
439401001 (SNOMED CT 2010_0731)
230690007 (SNOMED CT 2010_0731)
10042244 (MedDRA 13.1)
I63.9 (ICD-10-CM Version 2010)
E12826 (CTCAE Version 4.03)
102518004 (SNOMED CT 2010_0731)
10065527 (MedDRA 13.1)
103693007 (SNOMED CT 2010_0731)
10061816 (MedDRA 13.1)
10011603 (MedDRA 13.1)
422504002 (SNOMED CT 2010_0731)
10055221 (MedDRA 13.1)
230706003 (SNOMED CT 2010_0731)
10019005 (MedDRA 13.1)
81037000 (SNOMED CT 2010_0731)
10051078 (MedDRA 13.1)
405078008 (SNOMED CT 2010_0731)
246545002 (SNOMED CT 2010_0731)
10010916 (MedDRA 13.1)
386534000 (SNOMED CT 2010_0731)
53741008 (SNOMED CT 2010_0731)
10068617 (MedDRA 13.1)
I25.1 (ICD-10 Version 2009)
44808001 (SNOMED CT 2010_0731)
10003119 (MedDRA 13.1)
I49.9 (ICD-10-CM Version 2010)
427.9 (ICD-9-CM Version 2011)
155374007 (SNOMED CT 2010_0731)
10019279 (MedDRA 13.1)
I50 (ICD-10-CM Version 2010)
428 (ICD-9-CM Version 2011)
E10124 (CTCAE Version 4.03)
56265001 (SNOMED CT 2010_0731)
10061024 (MedDRA 13.1)
67507000 (SNOMED CT 2010_0731)